Scientists test new lithium to see if it reaches the brain better
NCT ID NCT06921590
Summary
This early-stage study aims to understand how a new crystalized form of lithium, called AL001, compares to a standard lithium pill. Six healthy volunteers will take both forms for two weeks each while staying in a hospital research unit. Researchers will use blood tests and brain scans to see how much of each drug gets into the brain and body, and to check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.